Stay updated on Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page
- Check7 days agoChange DetectedAn additional Revision: v3.6.3 has been added to the study record history and the previous v3.6.2 entry has been removed, reflecting an update to the record version in the history log.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page history now includes a new revision entry labeled v3.6.2 and removes the previous v3.6.0, indicating an updated record version. This reflects a backend/documentation refresh rather than changes to the study details.SummaryDifference0.1%

- Check21 days agoChange DetectedThe history view was redesigned, removing key navigation items and section labels such as Compare, Study Status, Contacts/Locations, Study Design, and Recruitment Status. A note indicates a new design and replacement of an older study version, signaling a structural change to the record history.SummaryDifference8%

- Check28 days agoChange DetectedA new revision entry v3.6.0 was added to the study record history, and the previous revision v3.5.5 was removed from the visible history. This reflects an update to the record-keeping design for the history log.SummaryDifference0.5%

- Check35 days agoChange DetectedThe Study Record History now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a newer revision of the record has been posted.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 and updating the page to the latest version in the study's history.SummaryDifference0.1%

Stay in the know with updates to Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.